(Q79926122)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18030300%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Adjuvant therapy with high-dose interferon alpha 2b in patients with high-risk stage IIB/III melanoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18030300%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

John M Kirkwood

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18030300%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Ahmad A Tarhini

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18030300%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Stergios J Moschos

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18030300%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Monica C Panelli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18030300%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

13 November 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18030300%20AND%20SRC:MED&resulttype=core&format=json

Nature Clinical Practice Oncology

27 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18030300%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18030300%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18030300%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18030300%20AND%20SRC:MED&resulttype=core&format=json

Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1004

7 January 2021

Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1004

7 January 2021

Neoadjuvant treatment of regional stage IIIB melanoma with high-dose interferon alfa-2b induces objective tumor regression in association with modulation of tumor infiltrating host cellular immune responses

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1004

7 January 2021

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1004

7 January 2021

High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1004

7 January 2021

A pooled analysis of eastern cooperative oncology group and intergroup trials of adjuvant high-dose interferon for melanoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1004

7 January 2021

Cost-effectiveness assessment of interferon alfa-2b as adjuvant therapy of high-risk resected cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1004

7 January 2021

Economic analysis of adjuvant interferon alfa-2b in high-risk melanoma based on projections from Eastern Cooperative Oncology Group 1684.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1004

7 January 2021

Prognostic significance of autoimmunity during treatment of melanoma with interferon.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1004

7 January 2021

Multiplex analysis of serum cytokines in melanoma patients treated with interferon-alpha2b.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1004

7 January 2021

Identifiers

DOI

10.1038/NCPONC1004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18030300%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference